Goserelin FDA Link

A synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic breast cancer.

Also Known As:

Zoladex; Goserelin Acetate; ICI-118630; Acetate, Goserelin; ICI 118630; ICI118630; Luteinizing hormone-releasing factor (pig), 6- (O- (1,1- dimethylethyl)- D- serine)- 10- deglycinamide- , 2-(aminocarbonyl)hydrazide

Pharmalogical Action Categories:

Antineoplastic Agents, Hormonal

Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Peptide Hormones: 1347
    - Hypothalamic Hormones: 68
      - Pituitary Hormone-Releasing Hormones: 39
        Gonadotropin-Releasing Hormone: 10670
        Goserelin: 757
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Nerve Tissue Proteins: 2
    - Neuropeptides: 6772
      - Hypothalamic Hormones: 68
        Pituitary Hormone-Releasing Hormones: 39
        Gonadotropin-Releasing Hormone: 10670
        Goserelin: 757
- Peptides: 82426
  - Neuropeptides: 6772
    - Hypothalamic Hormones: 68
      - Pituitary Hormone-Releasing Hormones: 39
        Gonadotropin-Releasing Hormone: 10670
        Goserelin: 757
  - Peptide Hormones: 1347
    - Hypothalamic Hormones: 68
      - Pituitary Hormone-Releasing Hormones: 39
        Gonadotropin-Releasing Hormone: 10670
        Goserelin: 757
  - Oligopeptides: 519
    - Gonadotropin-Releasing Hormone: 10670
      - Goserelin: 757

J Bolt Selected Research

J Bolt Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure